| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 111,70 | 111,95 | 26.07. | |
| 111,60 | 112,30 | 25.07. |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | KalVista, Biogen, Ionis get EU positive opinions for key drugs | ||
| Fr | Biogen's ZURZUVAE Wins EMA Panel Backing For Postpartum Depression Treatment | WESTON (dpa-AFX) - Biogen Inc. (BIIB), Friday announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has backed marketing authorization for ZURZUVAE... ► Artikel lesen | |
| Fr | Biogen Inc.: ZURZUVAE (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression | CAMBRIDGE, Mass., July 25, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a... ► Artikel lesen | |
| Di | Biogen to boost US manufacturing footprint with $2bn North Carolina investment | ||
| Di | Biogen to invest further $2bn in North Carolina's Research Triangle Park |
